QT Imaging Q3 scanner sales $0.9M (65% gross margin); amends convertible note to $8.6M; insider PIPE $2.56M

QT IMAGING HOLDINGS, INC.

2024-Q3 EPS reported -$0.77 revenue$4,032,168

Generated $0.9M scanner sales revenue with 65% gross margin in Q3 2024.
Completed engineering and clinical feasibility study with strategic partner.
Amended $10M convertible note with YA II PN: principal reduced to $8.6M, maturity extended to March 2026.
Board members and affiliates invested $2.56M PIPE at ~10% premium; surrened $1.56M note and $1M new cash.
Third-year renewal of NIH/NCI research grant signed during quarter.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.